CTN NIDA-CTN-0051A2 Treatment-as-Usual Opioid Use Outcomes Following Discharge from Detoxification and Short-Term Residential Programs Affiliated with NIDA CTN-0051
John Rotrosen, M.D. Feb 15, 2024
CTN NIDA-CTN-0030A3 Long-Term Follow-Up to CTN-0030 (A Two-Phase Randomized Controlled Clinical Trial of Buprenorphine/Naloxone Treatment Plus Individual Drug Counseling for Opioid Analgesic Dependence)
Roger Weiss, M.D. , Jennifer Sharpe Potter, Ph.D. Aug 22, 2014
CTN NIDA-CTN-0030 A Two-Phase Randomized Controlled Clinical Trial of Buprenorphine/Naloxone Treatment Plus Individual Drug Counseling for Opioid Analgesic Dependence
Walter Ling, M.D. , Roger Weiss, M.D. Jun 22, 2011
CTN NIDA-CTN-0010 Buprenorphine/Naloxone-Facilitated Rehabilitation for Opioid Dependent Adolescents/Young Adults
George Woody, M.D. Jul 30, 2009
CTN NIDA-CTN-0003 Suboxone (Buprenorphine/Naloxone) Taper: A Comparison of Two Schedules
Walter Ling, M.D. May 29, 2008
CTN NIDA-CTN-0002 Buprenorphine/Naloxone versus Clonidine for Outpatient Opiate Detoxification
Walter Ling, M.D. Jul 26, 2006
CTN NIDA-CTN-0001 Buprenorphine/Naloxone versus Clonidine for Inpatient Opiate Detoxification
Walter Ling, M.D. May 08, 2006
DTMC NIDA-CSP-1018 A Multicenter Safety Trial of Buprenorphine/Naloxone for the Treatment of Opiate Dependence
Walter Ling, M.D. , Paul J. Fudala, Ph.D. , Paul Casadonte, M.D. Sep 02, 2015
DTMC NIDA-CSP-1008B A Multicenter Safety Trial of Buprenorphine/Naloxone for the Treatment of Opiate Dependence
Peter Bridge, M.D. Dec 04, 2014
DTMC NIDA-CSP-1008A A Multicenter Efficacy/Safety Trial of Buprenorphine/Naloxone for the Treatment of Opiate Dependence
Peter Bridge, M.D. , Paul J. Fudala, Ph.D. Dec 04, 2014
